These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21828371)

  • 1. Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3.
    Poole EM; Tworoger SS; Hankinson SE; Schernhammer ES; Pollak MN; Baer HJ
    Am J Epidemiol; 2011 Sep; 174(6):642-51. PubMed ID: 21828371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.
    Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I
    Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies.
    Rice MS; Tworoger SS; Rosner BA; Pollak MN; Hankinson SE; Tamimi RM
    Breast Cancer Res Treat; 2012 Dec; 136(3):805-12. PubMed ID: 23085768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
    Oh H; Pfeiffer RM; Falk RT; Horne HN; Xiang J; Pollak M; Brinton LA; Storniolo AMV; Sherman ME; Gierach GL; Figueroa JD
    Int J Cancer; 2018 Aug; 143(3):496-507. PubMed ID: 29473153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
    Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
    Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trajectories of body fatness from age 5 to 60 y and plasma biomarker concentrations of the insulin-insulin-like growth factor system.
    Kværner AS; Hang D; Giovannucci EL; Willett WC; Chan AT; Song M
    Am J Clin Nutr; 2018 Aug; 108(2):388-397. PubMed ID: 30101328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body shape throughout life and correlations with IGFs and GH.
    Schernhammer ES; Tworoger SS; Eliassen AH; Missmer SA; Holly JM; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2007 Sep; 14(3):721-32. PubMed ID: 17914102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and risk of breast cancer in the Japan Collaborative Cohort study.
    Sakauchi F; Nojima M; Mori M; Wakai K; Suzuki S; Tamakoshi A; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():51-5. PubMed ID: 20553082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women.
    dos Santos Silva I; Johnson N; De Stavola B; Torres-Mejía G; Fletcher O; Allen DS; Allen NE; Key TJ; Fentiman IS; Holly JM; Peto J
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):449-55. PubMed ID: 16537700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
    Kajantie E; Fall CH; Seppälä M; Koistinen R; Dunkel L; Ylihärsilä H; Osmond C; Andersson S; Barker DJ; Forsén T; Holt RI; Phillips DI; Eriksson J
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II.
    Rice MS; Tamimi RM; Connolly JL; Collins LC; Shen D; Pollak MN; Rosner B; Hankinson SE; Tworoger SS
    Breast Cancer Res; 2012 Mar; 14(2):R44. PubMed ID: 22414675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of fetal, postnatal and childhood growth with insulin-like growth factor I and binding protein 3 in adulthood.
    Ben-Shlomo Y; Holly J; McCarthy A; Savage P; Davies D; Gunnell D; Davey Smith G
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):366-73. PubMed ID: 12919161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variability in IGF-1 and IGFBP-3 and body size in early life.
    Poole EM; Tworoger SS; Hankinson SE; Baer HJ
    BMC Public Health; 2012 Aug; 12():659. PubMed ID: 22894543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
    Hankinson SE; Willett WC; Colditz GA; Hunter DJ; Michaud DS; Deroo B; Rosner B; Speizer FE; Pollak M
    Lancet; 1998 May; 351(9113):1393-6. PubMed ID: 9593409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time spent walking or exercising and blood levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3): A large-scale cross-sectional study in the Japan Collaborative Cohort study.
    Wakai K; Suzuki K; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():23-7. PubMed ID: 20553077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Crowe FL; Key TJ; Allen NE; Appleby PN; Overvad K; Grønbæk H; Tjønneland A; Halkjær J; Dossus L; Boeing H; Kröger J; Trichopoulou A; Zylis D; Trichopoulos D; Boutron-Ruault MC; de Lauzon-Guillain B; Clavel-Chapelon F; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Gram IT; Rodríguez L; Jakszyn P; Molina-Montes E; Navarro C; Barricarte A; Larrañaga N; Khaw KT; Rodwell S; Rinaldi S; Slimani N; Norat T; Gallo V; Riboli E; Kaaks R
    Ann Hum Biol; 2011 Mar; 38(2):194-202. PubMed ID: 20731527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.
    DeLellis K; Rinaldi S; Kaaks RJ; Kolonel LN; Henderson B; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1444-51. PubMed ID: 15342444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.